VR Logo

Cipla Ltd.


Healthcare | Drugs & Pharma

we think vacations are for wimps

39 Stocks to buy right now

Join Value Research Stock Advisor now and be among the first to discover Stock Ideas

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

About The Company

Business: Manufacture of pharmaceuticals, medicinal chemical and botanical products

Incorporated: 1935

Chairman: Y K Hamied

Managing Director: Umang Vohra

Group: Cipla

Listing: NSE: CIPLA, BSE: 500087

Headquarters: Mumbai, Maharashtra

Website: www.cipla.com

Key Facts

Market cap: R 62,104.11 Cr

Revenue (TTM): R 17,489.13 Cr

Earnings (TTM): R 1,647.76 Cr

Cash: R 2,020.43 Cr

Total Debt: R 2,816.43 Cr

Promoters' ownership: 36.68%

Liquidity: High

52 Week range: R 355.30 - 819.30

Face value: R2.00

Shares outstanding: 80,63,37,456

10 Years Aggregate:

  • CFO: 17,217.19 Cr
  • EBITDA: 22,903.80 Cr
  • Net Profit: 13,244.30 Cr

Stock Performance

Time Period Cipla S&P BSE Sensex S&P BSE Healthcare
YTD61.04-11.3941.17
1 month2.99-5.79-1.58
3 months21.294.8315.45
1 Year77.20-6.5145.83
3 Years10.084.6110.96
5 Years3.667.161.48
10 Years9.306.1912.23
As on 25-Sep-2020
Year Cipla S&P BSE Sensex S&P BSE Healthcare
2019-8.5714.38-3.55
2018-14.555.87-5.89
20176.9827.910.49
2016-13.211.95-12.88
20153.40-5.0315.06
201455.9229.8947.43
2013-3.998.9822.55